Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57


Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.

Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P.

Oncotarget. 2018 Jun 19;9(47):28797. doi: 10.18632/oncotarget.25683. eCollection 2018 Jun 19.


PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?

Taïeb D, Foletti JM, Bardiès M, Rocchi P, Hicks RJ, Haberkorn U.

J Nucl Med. 2018 May;59(5):747-748. doi: 10.2967/jnumed.118.207993. Epub 2018 Feb 9. No abstract available.


TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression.

Baylot V, Karaki S, Rocchi P.

Results Probl Cell Differ. 2017;64:255-261. doi: 10.1007/978-3-319-67591-6_13.


Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.

Ziouziou H, Andrieu C, Laurini E, Karaki S, Fermeglia M, Oueslati R, Taieb D, Camplo M, Siri O, Pricl S, Katsogiannou M, Rocchi P.

Oncotarget. 2017 Aug 24;8(44):77317-77329. doi: 10.18632/oncotarget.20469. eCollection 2017 Sep 29. Erratum in: Oncotarget. 2018 Jun 19;9(47):28797.


Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer.

Karaki S, Benizri S, Mejías R, Baylot V, Branger N, Nguyen T, Vialet B, Oumzil K, Barthélémy P, Rocchi P.

J Control Release. 2017 Jul 28;258:1-9. doi: 10.1016/j.jconrel.2017.04.042. Epub 2017 May 1.


Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing.

Chen C, Posocco P, Liu X, Cheng Q, Laurini E, Zhou J, Liu C, Wang Y, Tang J, Col VD, Yu T, Giorgio S, Fermeglia M, Qu F, Liang Z, Rossi JJ, Liu M, Rocchi P, Pricl S, Peng L.

Small. 2016 Jul;12(27):3667-76. doi: 10.1002/smll.201503866. Epub 2016 May 31.


Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

Pasero C, Gravis G, Guerin M, Granjeaud S, Thomassin-Piana J, Rocchi P, Paciencia-Gros M, Poizat F, Bentobji M, Azario-Cheillan F, Walz J, Salem N, Brunelle S, Moretta A, Olive D.

Cancer Res. 2016 Apr 15;76(8):2153-65. doi: 10.1158/0008-5472.CAN-15-1965. Epub 2016 Apr 5.


The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.

Karaki S, Andrieu C, Ziouziou H, Rocchi P.

Adv Protein Chem Struct Biol. 2015;101:1-26. doi: 10.1016/bs.apcsb.2015.09.001. Epub 2015 Oct 23. Review.


The hallmarks of castration-resistant prostate cancers.

Katsogiannou M, Ziouziou H, Karaki S, Andrieu C, Henry de Villeneuve M, Rocchi P.

Cancer Treat Rev. 2015 Jul;41(7):588-97. doi: 10.1016/j.ctrv.2015.05.003. Epub 2015 May 9. Review.


Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.

Pasero C, Gravis G, Granjeaud S, Guerin M, Thomassin-Piana J, Rocchi P, Salem N, Walz J, Moretta A, Olive D.

Oncotarget. 2015 Jun 10;6(16):14360-73.


Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.

Lelj-Garolla B, Kumano M, Beraldi E, Nappi L, Rocchi P, Ionescu DN, Fazli L, Zoubeidi A, Gleave ME.

Mol Cancer Ther. 2015 May;14(5):1107-16. doi: 10.1158/1535-7163.MCT-14-0866. Epub 2015 Mar 4.


Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance.

Wei T, Chen C, Liu J, Liu C, Posocco P, Liu X, Cheng Q, Huo S, Liang Z, Fermeglia M, Pricl S, Liang XJ, Rocchi P, Peng L.

Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):2978-83. doi: 10.1073/pnas.1418494112. Epub 2015 Feb 23.


Heat shock protein 27 phosphorylation state is associated with cancer progression.

Katsogiannou M, Andrieu C, Rocchi P.

Front Genet. 2014 Oct 6;5:346. doi: 10.3389/fgene.2014.00346. eCollection 2014. Review.


Promoting siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer.

Liu X, Liu C, Zhou J, Chen C, Qu F, Rossi JJ, Rocchi P, Peng L.

Nanoscale. 2015 Mar 7;7(9):3867-75. doi: 10.1039/c4nr04759a.


The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.

Katsogiannou M, Andrieu C, Baylot V, Baudot A, Dusetti NJ, Gayet O, Finetti P, Garrido C, Birnbaum D, Bertucci F, Brun C, Rocchi P.

Mol Cell Proteomics. 2014 Dec;13(12):3585-601. doi: 10.1074/mcp.M114.041228. Epub 2014 Oct 2.


Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems.

Liu X, Zhou J, Yu T, Chen C, Cheng Q, Sengupta K, Huang Y, Li H, Liu C, Wang Y, Posocco P, Wang M, Cui Q, Giorgio S, Fermeglia M, Qu F, Pricl S, Shi Y, Liang Z, Rocchi P, Rossi JJ, Peng L.

Angew Chem Int Ed Engl. 2014 Oct 27;53(44):11822-7. doi: 10.1002/anie.201406764. Epub 2014 Sep 12.


Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system.

Liu X, Liu C, Chen C, Bentobji M, Cheillan FA, Piana JT, Qu F, Rocchi P, Peng L.

Nanomedicine. 2014 Nov;10(8):1627-36. doi: 10.1016/j.nano.2014.05.008. Epub 2014 Jun 3.


TCTP as therapeutic target in cancers.

Acunzo J, Baylot V, So A, Rocchi P.

Cancer Treat Rev. 2014 Jul;40(6):760-9. doi: 10.1016/j.ctrv.2014.02.007. Epub 2014 Mar 2. Review.


Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.

Liu C, Liu X, Rocchi P, Qu F, Iovanna JL, Peng L.

Bioconjug Chem. 2014 Mar 19;25(3):521-32. doi: 10.1021/bc4005156. Epub 2014 Feb 11.


Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.

de Thonel A, Hazoumé A, Kochin V, Isoniemi K, Jego G, Fourmaux E, Hammann A, Mjahed H, Filhol O, Micheau O, Rocchi P, Mezger V, Eriksson JE, Rangnekar VM, Garrido C.

Cell Death Dis. 2014 Jan 23;5:e1016. doi: 10.1038/cddis.2013.532.

Supplemental Content

Loading ...
Support Center